Filing metadata

Accession number
0001104659-22-095159
Form type
Form 3
Filer
Fulcrum Therapeutics, Inc.
CIK
CIK 1680581
Filed
Aug 26, 2022
Reporting period
Aug 16, 2022
Description
Initial ownership

Explore SEC Filings Hub